CAMCEVI J Code: J1952
Leuprolide injectable, camcevi, 1 mg
Q4 2026 Medicare Payment Limit for J1952, effective October 1, 2026: $36.373 per HCPCS billing unit, down 13.5% from $42.059. From CMS's final file.
Drug & Product Overview
About CAMCEVI
Camcevi is a medication aligned to the HCPCS J Code: J1952 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the subcutaneous route and manufactured by Accord.
According to CMS Drug Use Information: Leuprolide is used to treat advanced prostate cancer. It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment. Some brands of this medication are also used to stop early puberty (precocious puberty) in children. It helps to delay sexual development (such as growth of the breasts/testicles) and the start of menstrual periods. It also helps slow down early bone growth to increase the likelihood of reaching normal adult height. Leuprolide works by decreasing the amount of sex hormones that a child's body makes (estrogen in girls, testosterone in boys).
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Package | Manufacturer | HCPCS Units | WAC | AWP |
|---|---|---|---|---|---|
| 69448-0014-63 | 42 MGCamcevi Subcutaneous Injection 42 MG/.37G - 1 SYRINGE in 1 CARTON (69448-014-63) / .37 g in 1 SYRINGE | Accord BioPharma, Inc. | 42 | $4,270.07 $101.668 / unit | $5,124.08 $122.002 / unit |
| 69448-0023-63 | 42 MGCamcevi Subcutaneous Injection 42 MG/.37G - 1 SYRINGE in 1 CARTON (69448-023-63) / .37 g in 1 SYRINGE | Accord BioPharma, Inc. | 42 | $4,270.07 $101.668 / unit | $5,124.08 $122.002 / unit |
Effective 5/19/25 (WAC & AWP)
CAMCEVI Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.
Leuprolide Acetate 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J1950 | Abbvie | Leuprolide Acetate | Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
| J1951 | Tolmar Pharmaceuticals, Inc | Leuprolide Acetate | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg |
| J1952 | Accord | Leuprolide Acetate | Leuprolide injectable, camcevi, 1 mg |
| J1954 | Generic Code (Multiple Manufacturers) | Leuprolide Acetate | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg |
| J9217 | Generic Code (Multiple Manufacturers) | Leuprolide Acetate | Leuprolide acetate (for depot suspension), 7.5 mg |
CAMCEVI Claims Performance
Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.
Explore J1952 claims analytics on FocalPoint →
CAMCEVI CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96401 | Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic |
CMS does not include Camcevi (J1952) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1952. Wastage billing guide →
CAMCEVI Medically Unlikely Edits (MUE)
The most billing units of J1952 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
CAMCEVI Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Camcevi billing and coding guide?
Are there any available Camcevi patient assistance programs?
Where can I find Camcevi prescribing information?
Where can I find Camcevi side effect information?
Does billing CAMCEVI require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to CAMCEVI.